tiprankstipranks
Trending News
More News >
Isofol Medical AB (DE:5IU)
:5IU
Advertisement

Isofol Medical AB (5IU) Price & Analysis

Compare
2 Followers

5IU Stock Chart & Stats


Financials

5IU FAQ

What was Isofol Medical AB’s price range in the past 12 months?
Isofol Medical AB lowest stock price was €0.05 and its highest was €0.34 in the past 12 months.
    What is Isofol Medical AB’s market cap?
    Isofol Medical AB’s market cap is €26.38M.
      When is Isofol Medical AB’s upcoming earnings report date?
      Isofol Medical AB’s upcoming earnings report date is Nov 12, 2025 which is in 110 days.
        How were Isofol Medical AB’s earnings last quarter?
        Currently, no data Available
        Is Isofol Medical AB overvalued?
        According to Wall Street analysts Isofol Medical AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Isofol Medical AB pay dividends?
          Isofol Medical AB pays a Notavailable dividend of €0.069 which represents an annual dividend yield of N/A. See more information on Isofol Medical AB dividends here
            What is Isofol Medical AB’s EPS estimate?
            Isofol Medical AB’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Isofol Medical AB have?
            Isofol Medical AB has 281,107,240 shares outstanding.
              What happened to Isofol Medical AB’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Isofol Medical AB?
              Currently, no hedge funds are holding shares in DE:5IU

              Company Description

              Isofol Medical AB

              Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm, Merck & Cie, and Sahlgrenska University Hospital. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.
              Similar Stocks
              Company
              Price & Change
              Follow
              Xbrane Biopharma AB
              Xintela AB
              Ascelia Pharma AB
              Guard Therapeutics International AB
              Immunicum AB
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis